this is great Dr. Young! BRAVO!



StemCyte Expands Support of World Renowned Spinal Cord Injury Researcher Through Agreement with Rutgers University
Tuesday February 26, 8:00 am ET

StemCyte, Rutgers Sign Research, Licensing Agreement for Novel Human Umbilical Cord Blood Treatment for Spinal Cord Injury Being Developed by Wise Young, M.D., Ph.D.


NEW YORK, Feb. 26 /PRNewswire/ -- StemCyte Inc. and Rutgers, The State University of New Jersey, today announced at the Stem Cell Summit that they have entered into a research and licensing agreement for a spinal cord injury therapy being developed by Wise Young, M.D., Ph.D., that uses StemCyte's proprietary human umbilical cord blood (UCB) stem cells in conjunction with lithium.

more:

http://biz.yahoo.com/prnews/080226/nytu043.html?.v=101